Clinical development data update week 6
Clinical development data update for week 3 to 5
In 2021 NVGCT would like to provide weekly updates about ATMPs in clinical development. Happy reading!
Gene therapy for a subtype of eye disease approved in the Netherlands
From 2021, patients suffering from RPE65-associated retinal disease will be able to be treated in three UMCs of the Netherlands.
https://www.radboudumc.nl/nieuws/2020/gentherapie-voor-zeldzame-oogziekte-vergoed